Post-genomic Clinical Trials: the Perspective of ACGT
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Chen T, Wei J, Lei J, Chiu J, Shih K Front Oncol. 2021; 11:645853.
PMID: 33816299 PMC: 8010242. DOI: 10.3389/fonc.2021.645853.
Developing a European grid infrastructure for cancer research: vision, architecture and services.
Tsiknakis M, Rueping S, Martin L, Sfakianakis S, Bucur A, Sengstag T Ecancermedicalscience. 2012; 1:56.
PMID: 22275955 PMC: 3223975. DOI: 10.3332/ecms.2007.56.
References
1.
Jaffe C
. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol. 2006; 24(20):3245-51.
DOI: 10.1200/JCO.2006.06.5599.
View
2.
Gudjonsson T, Magnusson M
. Stem cell biology and the cellular pathways of carcinogenesis. APMIS. 2006; 113(11-12):922-9.
DOI: 10.1111/j.1600-0463.2005.apm_371.x.
View
3.
Eifel P, Axelson J, Costa J, Crowley J, Curran Jr W, Deshler A
. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. 2001; 93(13):979-89.
DOI: 10.1093/jnci/93.13.979.
View
4.
Kwoh C, Ng P
. Network analysis approach for biology. Cell Mol Life Sci. 2007; 64(14):1739-51.
PMC: 11136050.
DOI: 10.1007/s00018-007-7053-7.
View
5.
Yun Z, Keong K
. Identifying simple discriminatory gene vectors with an information theory approach. Proc IEEE Comput Syst Bioinform Conf. 2006; :13-24.
DOI: 10.1109/csb.2005.35.
View